Angina
Conditions
Interventions
A:Improved CSDP 10pills tid 28days
B:original CSDP 10pills tid 28days
Sponsors
Tianjin Tasly Pharmaceutical Group
Eligibility
Sex/Gender
All
Age
45 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Comply with Western stable angina pectoris (III level and below) diagnosed as the Qi stagnation blood stasis syndrome of TCM; 2. Average of weekly angina attacks in patients with >=2 times per week before 4 weeks before; 3. General performance with ischemic ECG: ST segment depression >=0.1mv and / or R-wave as the leading United T-wave inversion and deep> 0.2mv; normal ECG ST segment depression >=0.05mv, and <0.1 mv persons, treadmill test positive (see Program Annex: exercise stress test SOP); 4. Age 45-70 years old, male or female; 5. Signed informed consent.
Exclusion criteria
Exclusion criteria: 1. History of myocardial infarction, a preinfarction symptoms, resting angina occur from time to time, anything that might invalidate the results of the disease studies exist at least 3 months before; 2. Confirmed as acute myocardial infarction with coronary heart disease, IV grade (labor type) / severe (spontaneous) angina and other heart disease, severe neurosis, menopausal syndrome, hyperthyroidism, cervical disease, gall bladder heart disease, stomach and esophageal reflux, esophageal hiatal hernia, aortic dissection and other diseases other than coronary artery disease caused by chest pain; 3. Combined with hypertension and blood pressure by antihypertensive drug treatment were still higher (systolic blood pressure >=160mmHg, diastolic blood pressure >=100mmHg), severe heart and lung failure, severe arrhythmias (fast atrial fibrillation, atrial flutter, paroxysmal ventricular tachycardia, etc.), liver, kidney, hematopoietic system of primary and other serious diseases, mental illness; 4. Coronary artery disease by coronary bypass, interventional treatment of vascular completely rebuilt less than six months are; 5. Allergic to the drug component; 6. Pregnancy and prepare for pregnancy or breast-feeding women; 7. The law requires patients with disabilities (blind, deaf, mute, mental retardation, mental illness, etc.); 8. Over the past month to participate in other clinical trials of patients; 9. Over the past one month, used for liver and kidney function have a significant effect of the drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Angina Efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| SAQ;Nitroglycerin stop rate cut;Anticoagulation;Treadmill test;ECG effect; | — |
Countries
China
Contacts
Public ContactLanjun Sun
Outcome results
None listed